According to IMARC Group, the global oral proteins and peptides market, worth USD 1.8 Billion in 2024, is poised to grow at a 7.13% CAGR and reach USD 3.4 Billion by 2033. North America dominates with a 97.8% market share in 2024, fueled by cutting-edge developments in drug delivery systems and increasing demand for non-invasive therapies. Key growth drivers include the rising inciden... https://www.imarcgroup.com/oral-proteins-peptides-market